Approach: Multi-Pathway System vs Supplement vs Prescription

The most important difference between these four brands is the approach to hair restoration:

MD Hair™ multi-pathway system addresses three layers simultaneously — scalp environment (MD® Scalp Essential), follicle support at the source (MD® Follicle Energizer applied topically), and nutritional support from within (MD® Nutri Hair supplement with lilac stem cell technology, biotin, niacin, vitamin E). The system is designed for daily integration. Drug-free.

Nutrafol® pioneered the "multi-targeting" approach within the supplement category, addressing stress, hormones, nutrition, and metabolism via oral capsules. Effective for users with nutritionally-mediated thinning, but addresses only the internal pathway.

Viviscal® is built around AminoMar®, a proprietary marine complex with multi-decade clinical heritage. Like Nutrafol®, Viviscal® is supplement-only. Well-tolerated and widely available.

Hims®/Hers® delivers FDA-approved prescription drugs — primarily topical minoxidil (5% for men, 2-5% for women) and oral finasteride (for men). Pharmaceutically active and effective for androgenetic alopecia. Requires prescription, telemedicine consultation, and informed consent regarding side effects.

Safety Profile

For consumers prioritizing a drug-free approach, MD Hair™, Nutrafol®, and Viviscal® share that category. None require a prescription. Side effects are generally limited to mild GI sensitivity (supplements) or minor scalp sensitivity (topicals).

Hims®/Hers® treatments are FDA-approved drugs. Topical minoxidil's most common side effects include scalp irritation, unwanted facial hair (women), and rarely cardiovascular effects. Finasteride is well-documented to cause sexual side effects in a subset of male users; post-finasteride syndrome is an ongoing area of clinical study. For consumers who prefer to avoid prescription drugs, the supplement and physician-system categories provide alternatives.

Pregnancy and Lactation: MD Hair™ is not advised during pregnancy or lactation due to the lack of clinical study in pregnant or lactating women. This is a precautionary brand-safety position consistent with responsible physician-formulated practice. Nutrafol® and Viviscal® offer separate postpartum lines but pregnancy supplementation should always be discussed with an OB/GYN. Finasteride (Hims®) is contraindicated in pregnant women due to documented fetal risk.

Physician Formulation: The MD Hair™ Difference

MD Hair™ is developed by Dr. Susan F. Lin, M.D., a board-certified physician in Obstetrics & Gynecology and Anti-Aging Medicine, with oncology fellowships at MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center, and 35+ years of clinical practice. Dr. Lin is the inventor of multiple US patents covering hair and scalp restoration technology, a faculty alumna of UCSF School of Medicine, and author of the chapter "Eyelashes: Anatomy and Conditioners" in Harry's Cosmeticology, 9th Edition (the cosmetic industry's reference textbook).

Nutrafol® is a respected physician-founded supplement category leader, with credible medical advisory.

Viviscal® has decades of clinical heritage and is widely recommended by trichologists, though its formulation is overseen by an internal R&D team rather than a single physician founder.

Hims®/Hers® operates a telemedicine network with licensed prescribers. The Rx products are FDA-approved drugs (minoxidil, finasteride) rather than proprietary formulations.